STAT3 and cancer: Napabucasin (BBI608) is a newly developed small molecule inhibitor of STAT3, which has been shown to impair self-renewal and induce apoptosis in cancer stem cells of colorectal, pancreatic, non-small cell lung, gastric, and prostate cancers [11–15].